IN2014DN09347A - - Google Patents
Info
- Publication number
- IN2014DN09347A IN2014DN09347A IN9347DEN2014A IN2014DN09347A IN 2014DN09347 A IN2014DN09347 A IN 2014DN09347A IN 9347DEN2014 A IN9347DEN2014 A IN 9347DEN2014A IN 2014DN09347 A IN2014DN09347 A IN 2014DN09347A
- Authority
- IN
- India
- Prior art keywords
- compounds
- disorders
- substituents
- useful
- formula
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/38—Nitrogen atoms
- C07D231/40—Acylated on said nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pulmonology (AREA)
- Biomedical Technology (AREA)
- Physical Education & Sports Medicine (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261661958P | 2012-06-20 | 2012-06-20 | |
PCT/EP2013/062458 WO2013189862A1 (en) | 2012-06-20 | 2013-06-17 | Substituted pyrazole compounds as lpar antagonists |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2014DN09347A true IN2014DN09347A (hr) | 2015-07-17 |
Family
ID=48656033
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN9347DEN2014 IN2014DN09347A (hr) | 2012-06-20 | 2013-06-17 |
Country Status (22)
Country | Link |
---|---|
US (1) | US20150259295A1 (hr) |
EP (1) | EP2864294A1 (hr) |
JP (1) | JP2015520201A (hr) |
KR (1) | KR20150011003A (hr) |
CN (1) | CN104411690A (hr) |
AU (1) | AU2013279510A1 (hr) |
BR (1) | BR112014031108A2 (hr) |
CA (1) | CA2869602A1 (hr) |
CL (1) | CL2014003242A1 (hr) |
CO (1) | CO7160077A2 (hr) |
CR (1) | CR20140516A (hr) |
EA (1) | EA201492283A1 (hr) |
HK (1) | HK1206341A1 (hr) |
IL (1) | IL236091A0 (hr) |
IN (1) | IN2014DN09347A (hr) |
MA (1) | MA37765A1 (hr) |
MX (1) | MX2014014105A (hr) |
PE (1) | PE20142445A1 (hr) |
PH (1) | PH12014502364A1 (hr) |
SG (1) | SG11201407229UA (hr) |
UA (1) | UA109867C2 (hr) |
WO (1) | WO2013189862A1 (hr) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8975235B2 (en) | 2011-03-20 | 2015-03-10 | Intermune, Inc. | Lysophosphatidic acid receptor antagonists |
SG11201507459YA (en) | 2013-03-15 | 2015-10-29 | Epigen Biosciences Inc | Heterocyclic compounds useful in the treatment of disease |
CA2953472C (en) | 2014-06-27 | 2022-08-02 | Ube Industries, Ltd. | Halogen-substituted heterocyclic compound salt |
ES2962367T3 (es) * | 2017-12-19 | 2024-03-18 | Bristol Myers Squibb Co | Acidos carbamoil ciclohexílicos N-enlazados a pirazol como antagonistas de receptores del ácido lisofosfatídico (LPA) |
CN111434655A (zh) * | 2019-01-15 | 2020-07-21 | 武汉朗来科技发展有限公司 | 溶血磷脂酸受体拮抗剂及其制备方法 |
CA3158743A1 (en) | 2019-11-15 | 2021-05-20 | Gilead Sciences, Inc. | Triazole carbamate pyridyl sulfonamides as lpa receptor antagonists and uses thereof |
IL298082A (en) | 2020-06-03 | 2023-01-01 | Gilead Sciences Inc | lpa receptor antagonists and uses thereof |
WO2021247215A1 (en) | 2020-06-03 | 2021-12-09 | Gilead Sciences, Inc. | Lpa receptor antagonists and uses thereof |
WO2022240879A1 (en) * | 2021-05-11 | 2022-11-17 | Gilead Sciences, Inc. | Lpa receptor antagonists and uses thereof |
WO2023107938A1 (en) | 2021-12-08 | 2023-06-15 | Gilead Sciences, Inc. | Lpa receptor antagonists and uses thereof |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080249154A1 (en) * | 2003-12-26 | 2008-10-09 | Ono Pharmaceutical Co., Ltd. | Preventive and/or Therapeutic Agent For Disease In Which Mitochondrial Benzodiazephine Receptor Participates |
TW200827346A (en) | 2006-11-03 | 2008-07-01 | Astrazeneca Ab | Chemical compounds |
US20090036425A1 (en) | 2007-08-02 | 2009-02-05 | Pfizer Inc | Substituted bicyclolactam compounds |
GB2466121B (en) * | 2008-12-15 | 2010-12-08 | Amira Pharmaceuticals Inc | Antagonists of lysophosphatidic acid receptors |
GB2470833B (en) * | 2009-06-03 | 2011-06-01 | Amira Pharmaceuticals Inc | Polycyclic antagonists of lysophosphatidic acid receptors |
JP2013501064A (ja) * | 2009-08-04 | 2013-01-10 | アミラ ファーマシューティカルス,インコーポレーテッド | リゾホスファチジン酸受容体アンタゴニストとしての化合物 |
AU2011338561A1 (en) * | 2010-12-07 | 2013-07-25 | Amira Pharmaceuticals, Inc. | Lysophosphatidic acid receptor antagonists and their use in the treatment of fibrosis |
US8975235B2 (en) * | 2011-03-20 | 2015-03-10 | Intermune, Inc. | Lysophosphatidic acid receptor antagonists |
WO2012138648A1 (en) * | 2011-04-06 | 2012-10-11 | Irm Llc | Compositions and methods for modulating lpa receptors |
-
2013
- 2013-06-17 UA UAA201500427A patent/UA109867C2/ru unknown
- 2013-06-17 CN CN201380032266.8A patent/CN104411690A/zh active Pending
- 2013-06-17 US US14/402,128 patent/US20150259295A1/en not_active Abandoned
- 2013-06-17 JP JP2015517702A patent/JP2015520201A/ja active Pending
- 2013-06-17 EA EA201492283A patent/EA201492283A1/ru unknown
- 2013-06-17 SG SG11201407229UA patent/SG11201407229UA/en unknown
- 2013-06-17 AU AU2013279510A patent/AU2013279510A1/en not_active Abandoned
- 2013-06-17 EP EP13729940.0A patent/EP2864294A1/en not_active Withdrawn
- 2013-06-17 IN IN9347DEN2014 patent/IN2014DN09347A/en unknown
- 2013-06-17 KR KR1020147035552A patent/KR20150011003A/ko not_active Application Discontinuation
- 2013-06-17 MX MX2014014105A patent/MX2014014105A/es unknown
- 2013-06-17 BR BR112014031108A patent/BR112014031108A2/pt not_active Application Discontinuation
- 2013-06-17 WO PCT/EP2013/062458 patent/WO2013189862A1/en active Application Filing
- 2013-06-17 PE PE2014002212A patent/PE20142445A1/es not_active Application Discontinuation
- 2013-06-17 MA MA37765A patent/MA37765A1/fr unknown
- 2013-06-17 CA CA2869602A patent/CA2869602A1/en not_active Abandoned
-
2014
- 2014-10-22 PH PH12014502364A patent/PH12014502364A1/en unknown
- 2014-11-11 CR CR20140516A patent/CR20140516A/es unknown
- 2014-11-28 CL CL2014003242A patent/CL2014003242A1/es unknown
- 2014-12-04 IL IL236091A patent/IL236091A0/en unknown
- 2014-12-19 CO CO14279332A patent/CO7160077A2/es unknown
-
2015
- 2015-07-21 HK HK15106926.9A patent/HK1206341A1/xx unknown
Also Published As
Publication number | Publication date |
---|---|
CR20140516A (es) | 2014-12-01 |
WO2013189862A1 (en) | 2013-12-27 |
MX2014014105A (es) | 2015-03-05 |
CO7160077A2 (es) | 2015-01-15 |
PH12014502364A1 (en) | 2015-01-12 |
EP2864294A1 (en) | 2015-04-29 |
CN104411690A (zh) | 2015-03-11 |
AU2013279510A1 (en) | 2014-10-16 |
EA201492283A1 (ru) | 2015-04-30 |
BR112014031108A2 (pt) | 2017-06-27 |
KR20150011003A (ko) | 2015-01-29 |
CA2869602A1 (en) | 2013-12-27 |
PE20142445A1 (es) | 2015-01-28 |
SG11201407229UA (en) | 2014-12-30 |
JP2015520201A (ja) | 2015-07-16 |
MA37765A1 (fr) | 2017-04-28 |
IL236091A0 (en) | 2015-02-01 |
HK1206341A1 (en) | 2016-01-08 |
US20150259295A1 (en) | 2015-09-17 |
CL2014003242A1 (es) | 2015-03-20 |
UA109867C2 (ru) | 2015-10-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IN2014DN09352A (hr) | ||
PH12014502789A1 (en) | N-alkyltriazole compounds as lpar antagonists | |
IN2014DN09347A (hr) | ||
WO2014179564A8 (en) | Thiazolopyrrolidine inhibitors of ror-gamma | |
PH12016502378A1 (en) | Substituted dihydroisoquinolinone compounds | |
IN2014DN09434A (hr) | ||
IN2014MN02598A (hr) | ||
PH12014501514A1 (en) | New azetidine derivatives, pharmaceutical compositions and uses thereof | |
MX2014000341A (es) | Novedosos derivados de trifluoro-metil-oxadiazol y su uso en el tratamiento de enfermedades. | |
IN2015DN01119A (hr) | ||
PH12014501542A1 (en) | Substituted pyrrolidine -2- carboxamides | |
MX2016002794A (es) | Compuestos antiproliferativos. | |
PH12014501967B1 (en) | Benzodioxanes in combination with other actives for inhibiting leukotriene production | |
EA201500298A1 (ru) | Алкоксипиразолы в качестве активаторов растворимой гуанилатциклазы | |
WO2014045162A8 (en) | ALKYL-SUBSTITUTED HEXAHYDROPYRANO[3,4-d] [1,3]THIAZIN-2-AMINE COMPOUNDS | |
WO2013004995A8 (en) | Pyrimidinone compounds and their use | |
IN2014DN06869A (hr) | ||
MX340574B (es) | Imidazo pirazinas. | |
EA032271B9 (ru) | Вещества, фармацевтическая композиция и методы применения при лечении воспалительных заболеваний | |
MX2015001657A (es) | Compuestos de cianopirazol substituidos con receptores de acido lisofosfatidico (lpar). | |
MX2017013099A (es) | Metodos para el tratamiento de trastornos inflamatorios. | |
TN2017000342A1 (en) | Novel cyclopropabenzofuranyl pyridopyrazinediones | |
WO2015002755A3 (en) | Compounds for the treatment of malaria | |
WO2014160143A3 (en) | Isatin compounds, compositions and methods for treatment of degenerative diseases and disorders | |
MY166057A (en) | Carbocyclic nucleosides and their pharmaceutical use and compositions |